ConductScience.org, home

Paper8622014

Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.

Findlay M and 9 others. J Clin Oncol, 1996. Cited by 228 papers, by iCite.

Cite this record

ConductScience Library. Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. Papers, record 8622014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8622014

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.
PubMed
Journal
J Clin Oncol
PubMed
Year
1996
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
228
iCite
Relative citation ratio, by iCite
7.59
iCite
Revised in PubMed
2018-11-30
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Findlay MM
2Young HH
3Cunningham DD
4Iveson AA
5Cronin BB
6Hickish TT
7Pratt BB
8Husband JJ
9Flower MM
10Ott RR

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antimetabolites, AntineoplasticMajor topic
Antineoplastic AgentsMajor topic
Colorectal NeoplasmsMajor topic
DeoxyglucoseMajor topic
Fluorine RadioisotopesMajor topic
FluorouracilMajor topic
Interferon-alphaMajor topic
Liver NeoplasmsMajor topic
Tomography, Emission-ComputedMajor topic
Body Weight
Fluorodeoxyglucose F18
Humans
Interferon alpha-2
Recombinant Proteins

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in8622012Positron emission tomography in the clinical evaluation of metastatic cancer.https://conductscience.org/library/papers/8622012

Source PubMed

Download CSV of comments and corrections

Cited by57

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 228 citations.

PMIDTitleJournalYearIn PapersSource
42872124
Integrated Multi-Time-Point 18F-FAPI PET/CT and Immune Histopathology for Predicting Pathological Complete Response in Microsatellite-Stable Locally Advanced Rectal Cancer Treated With Neoadjuvant Radiotherapy, Chemotherapy, and Immunotherapy.
MedComm (2020)2026https://conductscience.org/library/papers/42872124PubMed
42230653Diagnostic Performance of 68Ga-FAPI PET/CT Versus 18F-FDG PET/CT in Evaluating Neoadjuvant Therapy Pathological Response in Breast Cancer.NPJ Breast Cancer2026https://conductscience.org/library/papers/42230653PubMed
37589901Performance of [18F]FDG PET/CT versus FAPI PET/CT for lung cancer assessment: a systematic review and meta-analysis.Eur Radiol2024https://conductscience.org/library/papers/37589901PubMed
36920590Harmonization of standard uptake values across different positron emission tomography/computed tomography systems and different reconstruction algorithms: validation in oncology patients.EJNMMI Phys2023https://conductscience.org/library/papers/36920590PubMed
36326867[68Ga]Ga-FAPI PET for the evaluation of digestive system tumors: systematic review and meta-analysis.Eur J Nucl Med Mol Imaging2023https://conductscience.org/library/papers/36326867PubMed
3300361518F-FDG PET/MR versus MR Alone in Whole-Body Primary Staging and Restaging of Patients with Rectal Cancer: What Is the Benefit of PET?J Clin Med2020https://conductscience.org/library/papers/33003615PubMed
31088837Magnetic Resonance Imaging Is More Sensitive Than PET for Detecting Treatment-Induced Cell Death-Dependent Changes in Glycolysis.Cancer Res2019https://conductscience.org/library/papers/31088837PubMed
28559939Comparison of Quantitative Methods on FDG PET/CT for Treatment Response Evaluation of Metastatic Colorectal Cancer.Nucl Med Mol Imaging2017https://conductscience.org/library/papers/28559939PubMed
28477166The accuracy of 18F-FDG PET/CT in predicting the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis and systematic review.Eur Radiol2017https://conductscience.org/library/papers/28477166PubMed
27072811Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer.Eur J Nucl Med Mol Imaging2016https://conductscience.org/library/papers/27072811PubMed
26739333Imaging metabolic heterogeneity in cancer.Mol Cancer2016https://conductscience.org/library/papers/26739333PubMed
26589835Prognostic significance of (18)FDG PET/CT in colorectal cancer patients with liver metastases: a meta-analysis.Cancer Imaging2015https://conductscience.org/library/papers/26589835PubMed
26396634Tumor SUVmax Normalized to Liver Uptake on (18)F-FDG PET/CT Predicts the Pathologic Complete Response After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.Nucl Med Mol Imaging2014https://conductscience.org/library/papers/26396634PubMed
26090365State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PET.Front Med (Lausanne)2015https://conductscience.org/library/papers/26090365PubMed
25831053Multimodality imaging to predict response to systemic treatment in patients with advanced colorectal cancer.PLoS One2015https://conductscience.org/library/papers/25831053PubMed
25763526Diagnostic accuracy of diffusion-weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to Y90-radioembolization.Invest Radiol2015https://conductscience.org/library/papers/25763526PubMed
25481195PET scans as a predictive marker of survival in advanced colorectal cancer.Clin Colorectal Cancer2015https://conductscience.org/library/papers/25481195PubMed
25290692Correlation between long-term aspirin use and F-fluorodeoxyglucose uptake in colorectal cancer measured by PET/CT.PLoS One2014https://conductscience.org/library/papers/25290692PubMed
24905030A randomized, phase II study of the anti-insulin-like growth factor receptor type 1 (IGF-1R) monoclonal antibody robatumumab (SCH 717454) in patients with advanced colorectal cancer.Cancer Med2014https://conductscience.org/library/papers/24905030PubMed
24833867Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantation.World J Gastroenterol2014https://conductscience.org/library/papers/24833867PubMed

See all 57 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IFNA23440PubTator's text mininghttps://conductscience.org/library/genes/3440

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8622014

GET https://conductscience.org/api/papers/v1/8622014/cited_by?page=2